|
High levels of homocysteine in pregnant women may
be a marker of risk for preeclampsia and umbilical placental vascular
disease, according to a new study.
-
Researchers studied plasma homocysteine levels
in the mother and fetus during the third trimester of 26 normal pregnancies
and 60 pregnancies with evidence of preeclampsia and placental vascular
disease.
-
Maternal plasma homocysteine levels were significantly
higher than normals in women with either of these problems.
-
Fetal homocysteine levels were also higher, particularly
for the preeclampsia group.
-
Infants in the affected groups were born earlier
than those in the normal group, and they weighed significantly less
at birth.
"In conclusion," the authors write, "our
study has shown that maternal plasma homocysteine levels are significantly
higher in pregnancy with preeclampsia and/or umbilical placental vascular
disease," and that their findings "suggest that elevated circulating
homocysteine may be involved in the pathogenesis of uteroplacental vascular
disease associated with preeclampsia, and a risk marker for this in the
mother."
Yet despite this new evidence as well as existing
studies showing dangers of elevated homocysteine during pregnancy, a researcher
told Reuters Health that "We do not yet have enough data to say homocysteine
should be measured routinely in pregnant women.
British Journal
of Obstetrics and Gynecology July, 2000;107:935-938.
|